IST:MEDTR Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,407	1,452	1,596	375.93	359.32
Revenue Growth (YoY)	-43.98%	-8.99%	324.48%	4.62%	-
Cost of Revenue	889.44	832.96	936.41	216.75	200.96
Gross Profit	517.38	619.31	659.33	159.18	158.36
Selling, General & Admin	317.55	288.48	241.54	66.76	63.56
Research & Development	14.92	13.9	6.54	2.45	0.84
Other Operating Expenses	3.34	54.73	25.38	0.88	-7.09
Operating Expenses	335.8	357.12	273.46	70.09	57.32
Operating Income	181.58	262.19	385.87	89.09	101.04
Interest Expense	-51.9	-52.71	-39.68	-13.37	-7.78
Interest & Investment Income	9.98	152.73	48.87	19.44	6.49
Earnings From Equity Investments	-4.39	-7.27	-1.97	-0.5	-1.13
Currency Exchange Gain (Loss)	89.32	112.3	190.45	107.6	-10.14
Other Non Operating Income (Expenses)	-148.27	-411.66	-387.57	-0.16	0.23
EBT Excluding Unusual Items	76.31	55.59	195.96	202.1	88.72
Gain (Loss) on Sale of Investments	-	-	-	-	-1.91
Other Unusual Items	-	-	-	-	-21.73
Pretax Income	76.31	55.59	195.96	202.1	65.08
Income Tax Expense	-52.05	29.68	81.66	34.4	4.65
Earnings From Continuing Operations	128.36	25.91	114.3	167.7	60.43
Minority Interest in Earnings	0.22	-0.04	0.03	-	-
Net Income	128.58	25.87	114.34	167.7	60.43
Net Income to Common	128.58	25.87	114.34	167.7	60.43
Net Income Growth	-	-77.38%	-31.82%	177.53%	-
Shares Outstanding (Basic)	119	119	119	119	95
Shares Outstanding (Diluted)	119	119	119	119	95
Shares Change (YoY)	-	-	-	25.93%	-
EPS (Basic)	1.08	0.22	0.96	1.41	0.64
EPS (Diluted)	1.08	0.22	0.96	1.41	0.64
EPS Growth	-	-77.36%	-31.85%	120.30%	-
Free Cash Flow	186.25	-4.22	-43.66	27.72	52.41
Free Cash Flow Per Share	1.57	-0.04	-0.37	0.23	0.55
Dividend Per Share	0.294	0.294	-	-	-
Gross Margin	36.78%	42.64%	41.32%	42.34%	44.07%
Operating Margin	12.91%	18.05%	24.18%	23.70%	28.12%
Profit Margin	9.14%	1.78%	7.17%	44.61%	16.82%
Free Cash Flow Margin	13.24%	-0.29%	-2.74%	7.37%	14.59%
EBITDA	233.55	310.83	431.95	100.13	112.23
EBITDA Margin	16.60%	21.40%	27.07%	26.64%	31.23%
D&A For EBITDA	51.97	48.64	46.08	11.04	11.19
EBIT	181.58	262.19	385.87	89.09	101.04
EBIT Margin	12.91%	18.05%	24.18%	23.70%	28.12%
Effective Tax Rate	-	53.39%	41.67%	17.02%	7.15%

Source: S&P Capital IQ. Standard template. Financial Sources.